Purchase Order W81K0216P0294
Award Date
9/8/16
Potential Completion Date
9/30/19
Potential Value
$117K
Federal Agency
Medical Command
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics and laboratory equipment. The $106,183.68 contract is for providing blood analysis equipment and associated testing services without any set-aside designation. Roche has received numerous awards from federal agencies, including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services,...
This is a firm fixed-price BPA call order awarded by the Medical Command (MEDCOM) of the U.S. Army to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of laboratory supplies. The award has a ceiling value of $12,469.11 and a period of performance ending on May 31, 2024. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services, and has a history of providing these...
This is a firm-fixed price delivery order awarded to Roche Diagnostics Corporation by the Defense Medical Command (MEDCOM) of the U.S. Army on September 1, 2015. The contract, valued at $3,082,805.38, is to provide chemistry reagents under the General Services Administration (GSA) Schedule contract for Critical Analyzers and Laboratory Equipment (FSS-66-III). The contract does not have a set-aside designation. Roche Diagnostics, as the prime contractor, will deliver the chemistry reagents to...
This is a federal contract award made by the Medical Command of the U.S. Department of Defense to Roche Diagnostics Corporation for reagent rental services. The contract has a ceiling value of $88,018.40 and is a firm fixed price delivery order with a period of performance ending on September 30, 2016. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided similar critical care equipment and supplies to various federal agencies through its General Services...
This federal contract was awarded by the Department of the Army Medical Command to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics and associated products and services. The $132,817.68 firm-fixed-price purchase order is for the delivery of ROCHE COBAS products and services. The contract has no set-aside designation and was awarded on October 1, 2019 with a completion date of October 31, 2020. Roche Diagnostics has...
This is a firm fixed-price delivery order contract awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the lease of a fully automated chemistry analyzer system with reagents, with a ceiling value of $2,240,104.51 and a period of performance through September 30, 2017. The contract does not have a set-aside designation. Roche Diagnostics has previously received...
This is a federal contract award to Roche Diagnostics Corporation (Roche Diagnostics) by the U.S. Air Force Materiel Command (AFMC) for medical and surgical instruments, equipment, and supplies. The contract has an ultimate completion date of September 30, 2017 and a ceiling value of $156,416.26. It is a delivery order contract with a firm fixed price pricing type. Roche Diagnostics has been awarded multiple General Services Administration (GSA) Schedule contracts and has provided critical...
This is a $108,863.73 fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract is for the provision of blood coagulation testing strips, without any set-aside designation. Roche Diagnostics has held multiple General Services Administration (GSA) Schedule contracts and Indefinite Delivery Vehicles (IDVs) with various federal...
This is a firm fixed-price BPA call awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation for COBAS AMPLIPREP/COBAS TAQMAN equipment and supplies. The contract has a ceiling value of $99,276.07 and an ultimate completion date of July 16, 2021. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments that has received numerous federal awards, including through General Services Administration (GSA) Schedule...
This $24,031.04 firm fixed price delivery order was awarded to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, by the Bureau of Medicine and Surgery, a Defense agency. The contract was placed against Roche's existing General Services Administration (GSA) Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits. The award provides laboratory supplies, which may include critical care analyzers, reagents, test...